This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ringbaekl, T J Articles by Lange, P Search for Related Content PubMed PubMed Citation Articles by Ringbaekl, T J Articles by Lange, P Pubmed/NCBI databases Medline Plus Health Information COPD (Chronic Obstructive Pulmonary Disease) Steroids Social Bookmarking                         What's this?

BMI and oral glucocorticoids as predictors of prognosis in COPD patients on long-term oxygen therapy

K Viskuml

Department of Respiratory Medicine, University Hospital of Copenhagen, Hvidovre, Denmark

P Lange

Department of Respiratory Medicine, University Hospital of Copenhagen, Gentofte, Denmark

Aims: The objectives of the study were to determine whether body mass index (BMI), and oral corticosteroid use predict survival and hospitalization in hypoxaemic chronic obstructive pulmonary disease (COPD) patients. Methods: The study was a prospective cohort study with analysis of a nationwide database (Danish Oxygen Register). We studied survival and hospitalization in 221 hypoxaemic COPD patients who were on long-term oxygen therapy (LTOT). Results: Low BMI was strongly associated with high mortality (P < 0.001). Maintenance treatment with steroids was only associated with higher mortality in overweight patients (BMI > 25 kg/mi²), RR = 3.8 (1.4-10.5), P = 0.011. Whereas BMI had no influence on risk of any hospitalization in patients using oral steroids, high BMI was independently associated with reduced risk of any hospitalization in patients without oral steroids [the RR of any hospitalization for each 1 kg/M² increase in BMI was 0.94 (CI: 0.90-0.99), P = 0.009]. Overall, the use of oral steroids was associated with increased risk of any hospitalization, RR = 1.7 (1.2-2.4), P = 0.002. This increase was especially pronounced in the group with BMI above 25 kg/M², where steroid treatment increased the risk of any hospitalization with RR = 3.6 (1.5-8.7), P = 0.005. Conclusions: In hypoxaemic patients on LTOT, low BMI is an independent risk factor of death and any hospitalization. Maintenance treatment with oral corticosteroids is associated with increased mortality and hospitalization in COPD patients with high BMI. Our findings suggest that loss of body weight should be avoided, and that oral corticosteroids should be used cautiously in patients on LTOT-especially those with high BMI. Further research on the role of changes in body composition as a prognostic factor is needed.

Key Words: corticosteroid • home care • hospitalization • nutrition • oxygen inhalation therapy • survival

Chronic Respiratory Disease, Vol. 1, No. 2, 71-78 (2004)
DOI: 10.1191/1479972304cd011oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?